ECG
NEXI

EPIQ Capital Group’s NexImmune, Inc. Common Stock NEXI Stock Holding History

EPIQ Capital Group’s Portfolio NEXI Stock Details NEXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-15,624
Closed -$43.1K – 76
2024
Q2 		$43.1K Hold
15,624
– – 0.02% 65
2024
Q1 		$87.7K Hold
15,624
– – 0.03% 64
2023
Q4 		$34.7K Hold
15,624
– – 0.02% 57
2023
Q3 		$82K Hold
15,624
– – 0.04% 52
2023
Q2 		$110K Hold
15,624
– – 0.06% 52
2023
Q1 		$148K Hold
15,624
– – 0.07% 49
2022
Q4 		$95K Hold
15,624
– – 0.05% 44
2022
Q3 		$217K Hold
15,624
– – 0.11% 45
2022
Q2 		$629K Buy
15,624
+8,000
+105% +$495K 0.25% 27
2022
Q1 		$802K Buy
+7,624
New +$560K 0.22% 29

Other funds holding NEXI

RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

EPIQ Capital Group's NEXI Position: Q3 2024 in Review

EPIQ Capital Group sold out of NexImmune, Inc. Common Stock (NEXI) in Q3 2024, closing a stake of 15,624 shares — an estimated $43.1K sold.

EPIQ Capital Group first reported a position in NEXI in Q1 2022 and held it in 10 quarters. The position peaked at $802K in Q1 2022. 1 fund tracked by Wall St. Rank holds NEXI as of Q3 2024.

  • EPIQ Capital Group reported no remaining NexImmune, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • EPIQ Capital Group sold 15,624 NexImmune, Inc. Common Stock shares in Q3 2024, an estimated $43.1K.
  • EPIQ Capital Group first reported a position in NexImmune, Inc. Common Stock in Q1 2022 and held it in 10 quarters.
  • EPIQ Capital Group's NexImmune, Inc. Common Stock position peaked at $802K in Q1 2022.
  • 1 fund tracked by Wall St. Rank held NexImmune, Inc. Common Stock as of Q3 2024.

Based on EPIQ Capital Group's 13F filing for Q3 2024, filed 14 Nov 2024.